ADA Scientific Sessions 2026 Abstract
Continuous Glucose Monitoring in Type 2 Diabetes Managed with Basal Insulin plus SGLT2 Inhibitor and/or GLP-1 Agonist: Subgroup Analysis from the FreeDM2 Trial
Trial in peopleInterventions
Papers by Emma Wilmot
2 results
- ADA Scientific Sessions 2025 Abstract
Real-World Data Comparing the Effectiveness of Injectable vs. Oral Semaglutide—Association of British Clinical Diabetologist (ABCD) National Audit
Study in peopleInterventions